FDA Home Page |
CFSAN Home | Search/Subject Index | Q & A | Help
Section IV. Guidance Documents
Chapter IV. Naturally Occurring Pathogens
Guide Contents
(
.01 Vibrio Risk Management for Oysters |
.02 Vibrio vulnificus Management Plan |
.03 Vibrio parahaemolyticus Interim Control Plan |
.04 Validation/Verification Interim Guidance )
.01 Vibrio Risk Management for Oysters
Background
Current information concerning Vibrio vulnificus, which is
responsible for several shellfish associated illnesses and deaths each
year can be found in Watkins and McCarthy (1994).
A small number of shellfish-borne illnesses have also been
associated with bacteria of the genus Vibrio (Bonner, 1983;
Blake et al.,1979; Morris, 1985; Joseph et al.,1982;
Roderick, 1982). The Vibrios are free-living aquatic
microorganisms, generally inhabiting marine and estuarine waters
(Joseph et al, 1982: Spira, 1984; Colwell 1984; Bachman, 1983
). Among the marine Vibrios classified as pathogenic are
strains of non-01 Vibrio cholerae, V. parahaemolyticus,
and V. vulnificus (Bachman, 1983; Desmarchelier, 1984; Blake,
1980). All three species have been recovered from coastal waters in the
United States and other parts of the world (Joseph, 1982; Colwell,
1984; Blake, 1980; DePoala, 1981; Madden, 1982; Davey, 1982; Oliver,
1983; Tamplin, 1982; NIH, 1984). These and other Vibrios have
been detected in some environmental samples recovered from areas free
of overt sewage contamination and coliform (Bonner, 1983; Joseph, 1982;
Spira, 1984).
In general, shellfish-borne vibrio infections have tended to occur
in coastal areas in the summer and fall when the water was warmer and
vibrio counts were higher (Bonner, 1983; Morris, 1985; Joseph, 1982). V. parahaemolyticus
and non-01 V. cholerae are commonly reported as causing
diarrhea illness associated with the consumption of seafood including
shellfish (Bonner, 1983; Blake, 1979; Morris, 1985; Joseph, 1982;
Baross and Liston, 1970; Morris, 1981). In contrast, V. vulnificus
has been related to two distinct syndromes: wound infections, often
with tissue necrosis and bacteria, and primary septicemia
characterized by fulminant illness in individuals with severe chronic
illnesses such as liver disease, hemochromatosis, thalassemia major,
alcoholism or malignancy (Bonner et al., 1983; Tacket, 1984).
Increasing evidence shows that individuals with such chronic diseases
are susceptible to septicemia and death from raw seafood, especially
raw oysters (Bonner et al., 1983; Blake, 1979; Morris, 1985;
Rodrick, 1982; Bachman, 1983; Blake, 1980; Oliver, 1983; NIH, 1984;
Tacket, 1984; Oliver 1982; FDA, 1985). Shellfish-borne vibrio
infections can be prevented by cooking seafood thoroughly, keeping them
from cross contamination after cooking, and eating them promptly or
storing them at hot (60°C or higher) or cold (4°C
or lower) temperatures. If oysters and other seafood are to be eaten
raw, consumers are probably at lower risk to vibrio infection during
months when seawater is cold than when it is warm (Blake, 1983 and
1984).
.02 Vibrio vulnificus Management Plan
The voting delegates at the 1999 Annual Meeting in New Orleans
created the Vibrio Management Committee (VMC). Subsequently, Vibrio
vulnificus and Vibrio parahaemolyticus subcommittees
have been charged to develop appropriate illness control measures for
these two pathogens. The VMC provides guidance and oversight to the
subcommittees. Subcommittee recommendations are reviewed by the VMC
before submittal to Task Forces. At the 2001 annual meeting, Task
Forces reviewed the VMC's recommendation of reducing the rate of
etiologically confirmed shellfish-borne Vibrio vulnificus
septicemia with the intention to submit the recommendation to the
voting delegates. The goal is to reduce the rate of illness reported in
California, Florida, Louisiana and Texas due to the consumption of
commercially harvested raw or undercooked oysters by 40 percent, for
years 2005 and 2006 (average) and by 60 percent for years 2007 and 2008
(average) from the average illness rate for the years 1995 - 1999 of
0.306/million. The list of states may be adjusted if after a thorough
review, epidemiological and statistical data demonstrates that it would
be appropriate. The rate of illness shall be calculated as the number
of illnesses adjusted for population. This adjustment will be performed
in consultation with statisticians and epidemiologists from California,
Florida, Louisiana and Texas and Federal agencies. The baseline data
and all future data for measuring illness reduction shall be the
reported illnesses in the California, Florida, Louisiana and Texas for
the period 1995 to 1999, inclusive, as compiled by the Southeast
Regional Office of the U.S. Food and Drug Administration. The data used
for measuring goal attainment shall begin with 2002 data. For the
purpose of maintaining an accurate count of the number of illnesses
report by each state (California, Florida, Louisiana and Texas), the
following will apply:
- (a)
Illness cases counted are those reported by California, Florida,
Louisiana and Texas;
- (b) Each
illness case is recorded under the state that reports it;
- (c) Each
case is not counted more than once; and
- (d) In the
event more than one report per case is filed, the case is recorded
under the state of diagnosis.
The formula for calculating the rate of illness is as follows:
number of cases
population
The V.v. subcommittee members will include, at a minimum, balanced
representation from industry and state shellfish control authorities
from Vibrio vulnificus Illness Source States California,
Florida, Louisiana and Texas, FDA, NOAA, EPA, CDC, state
epidemiologists; as well as industry and shellfish control
representatives from other regions. Vibrio vulnificus Illness
Source States are those states reporting two (2) or more etiologically
confirmed shellfish-borne Vibrio vulnificus illnesses since
1995 traced to the consumption of commercially harvested raw or
undercooked oysters that originated from the waters of that state.
Etiologically confirmed means those cases in which laboratory evidence
of a specific agent is obtained and specified criteria are met.
Recognizing the increasing importance and roles for the Committee,
leadership will be expanded and structured in a similar manner as
stated in the ISSC By-Laws for Task Forces (reference: ISSC By-Law,
Article I Task Forces). The VMC Chair shall alternately be selected
from a state shellfish control authority and from industry. The Board
Chairman, with approval of the Board, shall appoint a VMC Chair and
Vice-Chair. If the VMC Chair represents a state shellfish control
authority, the Vice-Chair shall be an industry representative. At the
end of the VMC Chair's term of office, the Vice Chair will become
Chairman and a new Vice Chair will be appointed who represents the same
segment of the Conference as the outgoing VMC Chair. A VMC Chair and
Vice Chair should be appointed before October 1, 2001 in order to be
consistent with plans for annual VMC meetings and with the effective
date of Vibrio vulnificus Risk Management Plans. Likewise,
the term of office shall be for (2) years.
The VMC will meet at least annually to develop and approve annual
VMC work plans for Vibrio vulnificus illness reduction and
review progress. A series of work plans, each covering a one-year
period shall be adopted. The first work plan and progress review period
will cover a seventeen-month period from August 1, 2001 to December 31,
2003 followed subsequently by annual work plans. Work plans will
include goals, tasks, performance measures and assessment methods to
track and achieve progress towards the illness reduction goals. The
work plans will be developed by the VMC and approved by the VMC
membership. The chair of the VMC will deliver a written annual progress
report, including a summary of the previous year's progress made in the
education program, to the ISSC March executive board meeting. The
report shall be made available to the general membership. The annual
work plan structure, outlined below, provides adaptive management and
assures consistent progress towards the illness reduction goals. If
annual assessment of progress towards achieving the illness rate
reduction goals show inadequate progress the VMC shall incorporate
actions into current and subsequent work plans to assure success in
achieving those goals. In addition, if annual review shows inadequate
progress the VMC will develop issues for deliberation at the 2005
biennial meeting to consider actions such as:
- increased educational efforts,
- limited harvest restriction,
- reduction in time from harvest to refrigeration,
- phased-in post-harvest treatment requirements, or
- other equivalent controls.
Work plans developed by the VMC shall include the following elements
and shall define the administrative procedures and resources necessary
for accomplishment (i.e. establishment and maintenance):
- (a) An
ISSC Consumer Education Program targeted toward individuals who consume
raw oysters and whose health condition(s) increase their risk for Vibrio
vulnificus infection. The Education Program's objectives will be
1) to increase the target audience's awareness that eating raw,
untreated oysters can be life-threatening to them, and; 2) to change
the at-risk group's oyster-eating behavior, i.e., to reduce or stop
eating raw, untreated oysters. The ISSC Vibrio Management Committee and
the Vibrio vulnificus Education Subcommittee will evaluate
Year 2001 survey results and compare them with the Year 2003 or 2004
survey results to determine the effectiveness in meeting the two
objectives of the Vv education effort: (1) Show 40% increase
in awareness of risk from Vv; and (2) Show 15% increase in at-risk
consumers no longer eating raw oysters while minimizing impacts to
non-at-risk consumer raw oyster consumption.
- (i)
The Consumer Education Program will focus educational efforts in
California, Florida, Louisiana and Texas. The Education Program will
make educational materials available to additional states upon request.
- (ii)
Educational approaches will emphasize partnerships with health and
advocacy organizations, and include dissemination of printed materials,
posting materials on the Internet, broadcast of television spots, press
releases, and other measures deemed effective such as the USDA
Physician Notification Program.
- (iii)
Survey assessments at the state level shall be used as a means of
assessing the baseline knowledge and effectiveness of educational
interventions.
- (b)
Administration of a survey to determine the current Vibrio
vulnificus disease reporting and education in each state.
- (c) Creation of a working
group to work cooperatively with local, state, and federal agencies and
programs to assist in the collection of environmental and
epidemiological data to further expand on the current information
available. A coordinator may be utilized to facilitate the activities
of this working group to develop standardized collection of
environmental and epidemiological information from harvest to consumer.
- (d) The Voting Delegates at the 2007 Biennial Meeting in Albuquerque, New Mexico approved appointment of a committee that will consist of three (3) epidemiologists and advisors as appropriate. The Committee will use this form to screen cases for the purposes of determining if a case is attributable to a single source state as well as whether the case is includable in the Vv Illness Reduction Goals. In addition, to ensure uniformity, the form shall be used for screening 2007-2008 cases and that cases from the baseline will be screened using the same form.
Criteria FOR INCLUDING Vv CASES IN ILLNESS REDUCTION CALCULATIONS and determining source states
- Each case that is considered must be reported on a Center for Disease Control and Prevention Cholera and Other Vibrio Illness Surveillance Report (COVIS) Form CDC 52.79.
- Each case must also be listed be on the FDA database (NSSP Guide for the Control of Molluscan Shellfish Guidance Documents Chapter IV .02).
- The ISSC committee to review reported Vv illnesses to determine the appropriateness of inclusion into the database used for illness reduction calculations must have access to the COVIS form for each case (patient names and other necessary information appropriately redacted). The ISSC addendum form is also provided, where available. This access to the COVIS form is critical for adequate interpretation of the data collected during the state epidemiological investigation.
- The ISSC Vv Illness Review Committee will complete the following criteria table for each case. These tables serve as documentation.
- For cases to be included in illness reduction calculations the following criteria must be met:
- Item 1-4 and 5a must be answered yes.
- Should the COVIS form include information that suggests other exposures that may be responsible for the Vv illness further investigation may occur. Consultation with State Shellfish Control Authorities and Epidemiologist from the state is encouraged to determine which exposure should be recorded as the cause of illness. Should oyster consumption not be determined to be the cause of illness the case will not be counted. Should there be disagreements with the inclusion of a case; the disagreeing party may request a review. The request must include a rationale for the review and should be addressed to the Executive Board Chairman.
- If 5b is no, other exposures should be considered. If no other exposures exist, the case will not be counted.
- Should the only exposure be consumption of cooked oysters or unknown 5b will be checked yes.
Vibrio vulnificus Criteria Table
Case Identifier / Number ______________ |
Criteria Status Determination |
Criteria |
Yes |
No |
Unknown |
1. Etiologically Confirmed |
|
|
|
2. Septicemia Illness |
|
|
|
3. Reporting State (CA, FL, LA, TX) |
|
|
|
4. Commercial Harvest from US Production |
|
|
|
5. Exposures |
|
|
|
a. Onset Consistent with Consumption of Oysters |
|
|
|
b. Raw or undercooked oysters |
|
|
|
6. Traceback Information |
|
|
|
a. Were shipping tags available or was other traceback information reported |
|
|
|
b. State of harvest and harvest area (s) |
|
|
c. Harvest date (s) |
|
|
7. Case Determination |
|
|
|
a. Is case included in Vv illness reduction Calculations |
|
|
|
b. Is case attributed to a single source state |
|
|
|
Instructions for completing Criteria Table:
- Check YES if Criterion is confirmed from the COVIS form or addendum.
- Check NO if Criterion is not confirmed from the COVIS form or addendum.
- Check UNKNOWN if Criterion is not clear or absent from the COVIS form or addendum.
- No Criterion can have more than one check entered.
- Each Criterion must have one check entered (YES, NO, or UNKNOWN).
These criteria tables will be used to review reported Vv illnesses to determine the appropriateness of inclusion into the database used for illness reduction calculations and will also be used for identifying other source states. |
- (e) Industry-implemented
post-harvest controls to reduce Vibrio vulnificus levels in
oyster shellstock which may include: time-temperature, post harvest
treatment (i.e. hydrostatic pressure, cool pasteurization, IQF, and
irradiation--pending approval), rapid chilling and other emerging
technologies.
- (f) Pursuit of ISSC
options such as industry education and communication; FDA label
incentives; PHT specific growing area classifications; targeted
time/temperature assessment by FDA during annual shellfish program
evaluations; assistance, as necessary, for the further study and
possible implementation of dockside icing to investigate its effects on
shelf life and variations in the effectiveness of the method as a
result of seasonal and regional differences and incentives to add
refrigeration capacity to harvest vessels. The goal will be to provide
incentives necessary to post-harvest treat 25 percent of all oysters
intended for the raw, half-shell market during the months of May
through September harvested from a Source State by the end of the third
year (December 31, 2004). The assessment will include the capacity of
all operational plants and the capacity of plants under construction.
Should the 25 percent goal not be accomplished, the VMC will
investigate and report their findings as to why the goal was not
reached.
- (g)
Development by the VMC of a list of issues relating to public health,
various technologies including Post-harvest treatments; marketability;
shelf -life and similar matters that lend themselves to investigation.
The VMC will work with FDA, NOAA, CDC, EPA, the shellfish industry and
other entities as appropriate to obtain or facilitate the investigation
of the issues listed and take the results into account as it develops
plans or recommended Issues for the ISSC.
- (h) Provision for VMC
compilation and review of the data on rates of illness, which will be
made available to the ISSC at the ISSC Biennial meeting following the
year in which the data was gathered. In the event that the data is not
available at the time of the meeting, the VMC shall meet and review the
data when it becomes available and issue a compilation report, which
will be made available to the entire ISSC membership. In the event
there is no Biennial meeting scheduled for a certain year, the VMC
shall meet and review the data when it becomes available and issue a
compilation report which will be made available to the entire
membership.
- (i)
Provision for a VMC evaluation of the effectiveness of reduction
efforts, which will be conducted at the end of the fifth year (December
31, 2006). The evaluation will determine whether the 40 percent, 5-year
goal to reduce the rate of illness or education/consumer intervention or
post harvest controls performance measures set forth in prior work
plans have been achieved. Should the VMC evaluation indicate the 40
percent, 5 year goal has not been accomplished, the committee will
identify additional harvest controls in the 2007 - 2008 work plan to
assure achievement of the 60 percent reduction in the rate of
illness goal by the close of the seventh year. In addition, the VMC will
evaluate the requirements in Section 04.C. with the possibility of
changing the controls to achieve remaining illness reduction goals.
Should a disagreement arise between FDA and the Authority on the
equivalency of a control as described in .04(C), the V.v. Subcommittee
will be requested to provide guidance.
In 2006 the Executive Board directed the elimination of the Vv & Vp subcommittees. The VMC assumed all responsibilities of the subcommittees as outlined in the Vibrio vulnificus Management Guidance Document. Representation on the VMC Committee will be consistent with all guidance (VMC and Vv subcommittee) outlined in the Vibrio vulnificus Management Guidance Document.
.03 Vibrio parahaemolyticus Control Plan Guidance
- Risk Evaluation
The determination of Reasonably Likely to
Occur should be conducted as follows:
- A risk evaluation as described in Proposal
07-202 (with the understanding that ISSC has not adopted nor endorsed the FDA Vp Risk Assessment); or
- The risk factor decision tree under
development by the VMC using the risk factors included in Proposal 07-202; or
- Other approaches approved by the State
Authority that provide at least an equivalent level of protection and reduce
the risk so that it no longer constitutes an annual occurrence.
- Vibrio parahaemolyticus Control Plan
- Triggers
A plan for an area(s) or a state must include control
measures for the month(s) in which:
- The total number of Vp illnesses is
two or more in a three (3) year period; or
- The area was epidemiologically linked to an
outbreak within the prior five (5) years and the plan must also apply to the
period 30 days prior to the first day of harvest of the outbreak and 30 days after
the last day of harvest associated with the outbreak; or
- The average water temperatures
representative of harvesting conditions exceed 60 °F for states
bordering the Pacific Ocean and 81 °F for states bordering the Gulf
of Mexico and Atlantic Ocean (New Jersey and south). See exemption in the NSSP Model Ordinance Chapter II.@.05.B.2.; or
The regulatory authority to administer this plan is [To be filled in by the Authority].
- Control Measures
- Post Harvest Processing (PHP).
- Closing the area to oyster
harvest.
- Restrict oyster harvest to product
labeled "For Cooking Only."
- Limit time from harvest to
refrigeration to no more than five (5) hours or other times based on modeling
and sampling in consultation with FDA.
- Limit time from harvest to
refrigeration such that levels of total Vp after completion of cooling
to 60 °F do not increase more than 0.75 log from levels at harvest.
Calculations for 0.75 log increase can be based on the table as shown below or
based on validation studies. The authority may use the FDA Risk Assessment to
determine the initial "at harvest" levels.
- The term refrigeration is storage
in a container that is capable of dropping and maintaining ambient air
temperature of 45 °F (7.5 °C).
- Other control measures based on
appropriate scientific studies
- Plan Effectiveness as Demonstrated by:
- Post Harvest Processing.
Conduct
end product testing consistent with PHP verification protocol as provided in
the NSSP Guide for the Control of Molluscan Shellfish. Test results shall
demonstrate the level of total Vp in the final product does not exceed
the average levels found in the area at times of the year the state had
determined Vp illness is not reasonably likely to occur.
Data
may be shared between states or other entities as may be appropriate
considering the characteristics of the harvest area(s), such as temperature,
hydrological patterns, etc. In the absence of such state data, use 100/gm for
the Pacific and 1000/gm for the Atlantic/Gulf as provided in the FDA Risk
Assessment.
Note: These levels are significantly higher than those
allowed in validation/verification to non-detectable. Labeling "for
added safety" would not be permitted unless the lower levels were reached.
- Closing the area to oyster
harvest.
Issue a
legally binding closure order(s). Conduct Patrol and maintain Patrol records
for the area(s) in accordance with the NSSP MO requirements.
- Restrict oyster harvest to product
labeled "For Cooking Only" or "For PHP Only."
The
authority must notify harvesters and dealers of those areas restricted to
harvest "For Cooking Only" or "For PHP Only."
Harvesters must include on the tag of all product harvested in these areas the
statement "For Cooking Only" or "For PHP Only." Dealers
must establish a "For Cooking Only" or "For PHP Only"
labeling Critical Limit as part of their HACCP plan for receiving. A shipping
Critical Control Point must include a "For Cooking Only" or
"For PHP Only" labeling requirement.
- Limit time from harvest to
refrigeration to no more than five (5) hours or other times based on modeling
and sampling in consultation with FDA. Compliance may be documented by State
restriction orders, harvester records, dealer records, field records, storage
records, harvester education/inspections, records of capable and operating
refrigeration.
- Limit time from harvest to
refrigeration such that levels of total Vp after completion of cooling to 60 °F
do not increase more than 0.75 log from levels at harvest. Calculations for
0.75 log increase can be based on the table as shown below or based on
validation studies. The authority may use the FDA Risk Assessment to determine
the initial "at harvest" levels.
- The term refrigeration is storage
in a container that is capable of dropping and maintaining ambient air
temperature of 45°F (7.5°C).
- Other control measures based on
appropriate scientific studies
- Plan Modification
- Cost Benefit Analysis (Optional)
Temperature specific Vp Growth rates and Doubling times for calculating cumulative growth
based on hourly temperature observations.
Oyster Temperature (degree F) |
Growth rate (logs/hr) |
doubling time (hrs) |
Oyster Temperature (degree F) |
Growth rate (logs/hr) |
doubling time (hrs) |
50 |
0.008 |
35.8 |
|
|
|
51 |
0.011 |
28.4 |
76 |
0.147 |
2.05 |
52 |
0.013 |
23.1 |
77 |
0.156 |
1.93 |
53 |
0.016 |
19.2 |
78 |
0.165 |
1.83 |
54 |
0.019 |
16.1 |
79 |
0.174 |
1.73 |
55 |
0.022 |
13.8 |
80 |
0.183 |
1.64 |
56 |
0.025 |
11.9 |
81 |
0.193 |
1.56 |
57 |
0.029 |
10.4 |
82 |
0.203 |
1.48 |
58 |
0.033 |
9.14 |
83 |
0.213 |
1.41 |
59 |
0.037 |
8.11 |
84 |
0.224 |
1.34 |
60 |
0.042 |
7.24 |
85 |
0.235 |
1.28 |
61 |
0.046 |
6.50 |
86 |
0.246 |
1.23 |
62 |
0.051 |
5.87 |
87 |
0.257 |
1.17 |
63 |
0.056 |
5.33 |
88 |
0.268 |
1.12 |
64 |
0.062 |
4.86 |
89 |
0.280 |
1.07 |
65 |
0.068 |
4.45 |
90 |
0.292 |
1.03 |
66 |
0.074 |
4.09 |
91 |
0.304 |
0.99 |
67 |
0.080 |
3.77 |
92 |
0.317 |
0.95 |
68 |
0.086 |
3.49 |
93 |
0.330 |
0.91 |
69 |
0.093 |
3.24 |
94 |
0.343 |
0.88 |
70 |
0.100 |
3.01 |
95 |
0.356 |
0.85 |
71 |
0.107 |
2.81 |
96 |
0.370 |
0.81 |
72 |
0.115 |
2.63 |
97 |
0.383 |
0.79 |
73 |
0.122 |
2.46 |
98 |
0.397 |
0.76 |
74 |
0.130 |
2.31 |
99 |
0.412 |
0.73 |
75 |
0.139 |
2.17 |
100 |
0.426 |
0.71 |
Note: Growth rate (in logs/hr) = (0.01122*Temp – 0.4689)^2
References
- Bachman, B. et al. 1983. Marine Noncholera Vibrio
Infections in Florida. So. Med. Jour. 76:296-303.
- Baross, J. and J. Liston. 1970. Occurrence of Vibrio
parahaemolyticus and Related Hemolytic Vibrios in Marina
Environments of Washington State. Appl. Microbiol. 20:179-186.
- Blake, P.A. et al. 1979. Disease Caused by a Marine
Vibrio, Clinical Characteristics and Epidemiology. N. Eng. J. Med.
300: 1-5.
- Blake, P.A. et al. 1980. Disease of Humans (Other Than
Cholera Caused by Vibrios). Ann. Rev. Microbiol. 34:341-367.
- Blake, P.A. 1983. Vibrios on The Half Shell: What the Walrus and the
Carpenter Didn't Know. Ann. of Int. Med. 99:558-559.
- Blake, P.A. 1984. Prevention of Food-Borne Disease Caused by Vibrio
Species. In: Colwell, R.R., et al., eds. Vibrios in the Environment.
John Wiley and Sons. New York, NY. pp. 579-590.
- Bonner, J.R. et al. 1983. Spectrum of Vibrio Infections in
a Gulf Coast Community. Ann. Intern. Med. 99:464-469.
- Colwell, R.R. 1984. Vibrios In The Environment In: Colwell, R.R.; et
al., eds. Vibrios in the Environment. John Wiley & Sons.
New York, NY. pp. 1-12.
- Davey, G.R. et al. 1982. Detection of Vibrio cholerae In Oysters, Water And Sediment From The Georges River. Food
Technol. Aust. 34:334-336.
- DePaola, A. 1981. Vibrio cholerae in Marine Foods and
Environmental Waters. A literature review. Jour. of Food Sci.
46:66-70.
- Desmarchelier, P.M. 1984. Significance Of Vibrio spp. in
Foods. Food Technol. Aust. 36:220-222.
- Food and Drug Administration. 1985. Vibrio vulnificus and
Patients with Liver Disease. In: FDA Drug Bulletin. April.
15(1):5-6.
- Joseph, S.W. et al. 1982. Vibrio parahaemolyticus And Related Halophilic Vibrios. CRC Crit. Rev. in Microbiol.
10:77-124.
- Madden, J.M. et al. 1982. Vibrio cholerae. In
Shellfish From U.S. Coastal Waters. Food Tech. 36(3):93-96.
- Morris, J.G. Jr. et al. 1981. Non-O group 1 Vibrio
cholerae Gastroenteritis in the United States. Ann. of Int.
Med. 94:656-658.
- Morris, J.G., Jr. et al. 1985. Cholera And Other Vibrioses In The United States. N. Engl. J. Med. 312:343-350.
- National Institute of Health (NIH). 1984. Highly Invasive New
Bacterium Isolated From U.S. East Coast Waters. JAMA.
251:323-325.
- Oliver, J.D. 1982. The Pathogenicity and Ecology of Vibrio
vulnificus. Marine Tech. Soc. Jour. 15:45-52.
- Oliver, J.D. et al. 1983. Distribution of Vibrio
vulnificus and Other Lactose-Fermenting Vibrios in The Marine
Environment. Appl. Environ. Microbiol. 45:985-998.
- Rodrick, G.E. et al. 1982. Human Vibrio Gastroenteritis,
Symposium On Intestinal Infections. Med. Clinics of North Amer.
66:665-673.
- Spira, W.M. 1984. Tactics For Detecting Pathogenic Vibrios In The
Environment. In: Colwell, R.R. et al., eds. Vibrios in
the Environment. John Wiley & Sons. New York, NY pp 251-268.
- Tacket, C.O., et al. 1984. Clinical Features and an Epidemiological
Study of Vibrio vulnificus Infections. Jour. Infect. Dis.
149:558-561.
- Tamplin, M., et al. 1982. Isolation and Characterization of Vibrio
vulnificus From Two Florida Estuaries. Appl. Environ.
Microbiol. 44:1466-1470.
- Watkins, W. and S. McCarthy. 1994. Proceedings of the 1994
Vibrio vulnificus Workshop. U.S. Department of Health and Human
Services, Public Health Service, Office of Seafood (HFS-400), Shellfish
Sanitation Branch, 200 C Street, SW, Washington, D.C. 175 pages.
.04 Post Harvest Processing (PHP) Validation/Verification Guidance for Vibrio vulnificus and Vibrio parahaemolyticus
- Process Validation
Used for the initial validation
of a process or when there has been a change to a previous validation process.
- Data on ten processed samples
obtained on each of three processing days (total of 30 samples) are required.
- All samples used on a processing
day must come from the same lot of shellfish and be determined to have an
adjusted geometric mean (AGM) MPN of
10,000 per gram or greater as described below for initial load testing.
- Samples should be distributed
throughout the processing day. A sample will consist of a composite of 10
to 12 oysters processed at one time.
- The zero hour level may be
achieved through naturally occurring Vibrio levels in shellfish and, where
not practical, by time/temperature abuse.
(Inoculated pack samples may be used as appropriate.)
- Analytical methodology to determine
Vibrio levels should be the official methods previously endorsed by the ISSC as indicated in Model Ordinance Chapter XVI. Post Harvest Processing.
- Microbiological testing for initial levels will be by a 3-tube MPN using appropriate dilutions (10-1 to 10-6).
- Microbiological testing for processed samples will be by a single dilution five-tube MPN, inoculating with either 0.01 g or 0.1 g of shellfish per tube based upon the table below.
- The numerical value of the endpoint criteria should be less than 30 per gram and achieves a minimum 3.52 log reduction.
- For the process to be validated, no more than three samples out of 30 may fail. Depending upon the initial load, failure of a single sample is determined according to the table below.
AGM Interval |
Grams Per Tube |
Positive Tubes Allowed |
59,995 or Greater |
.01 |
2 |
37,174 – 59,994 |
.01 |
1 |
23,449 – 37,173 |
.1 |
4 |
12,785 – 23,448 |
.1 |
3 |
10,000 – 12,784 |
.1 |
2 |
For example, if the AGM equals 50,000, then use the second row because 37,174 ≤50,000 < 59,994. The second row tells to inoculate with .01 grams of the original oyster homogenate in each tube and the test fails if more than one of the five tubes is positive.
- Equipment Validation
Used to ensure that each new or modified unit of
equipment will deliver the validated process. May be accomplished using the following:
- A physical test of the equipment
(e.g., thermal distribution study) that is designed to ensure that, when
properly operated, it will
consistently deliver the validated process.
- The process needs to be verified according to section D. before labeling claims can be made.
- Initial Load Testing
Initial level of vibrios in
shellfish for each lot of shellfish used in validation shall be 10,000 MPN per
gram or greater based on the adjusted geometric mean (AGM) of the MPNs/g of
four samples where the AGM is given by:
AGM = the
geometric mean of the 4 MPNs/g multiplied by an adjustment factor of 1.3
Note: If 4 samples from a lot of
shellfish with a true density of 100,000 cells per gram are examined by the MPN
procedure, the probability of the geometric mean of the MPNs showing 100,000 or
greater is about 50%. In an attempt to improve the probability of samples
being accepted when the true density is 100,000/g an adjustment factor of 1.3
was selected based upon statistical analysis.
- Verification
Used to verify that a previously
validated process is working properly.
- Process verification by
microbiological testing should be done monthly
- The monthly sampling shall consist of 30 tubes from a minimum of three samples of 10 tubes each with an innoculum of 0.01 grams. Ideally, this would be done on three separate days of production, spread throughout the month, using a 10 tube MPN each day. If this is not feasible, the 30 tubes can consist of 3 samples from three consecutive days or 3 samples from a given day (from three separate lots if possible)
- Each sample will consist of 10-12 oysters
- If more than 11 tubes of the 30 most recent 3-10 tube samples within any calendar month are positive, then the process fails for that month. In this case, corrective actions as outlined in the Verification Sampling Plan Decision Tree must be taken and verification must be repeated within one week of the analysis indicating verification failure. Labeling claims may not be used during this time.
- If all ten tubes are positive for any given sample, this is considered a verification failure and corrective actions must be taken immediately regardless of the result of the other samples for that month.
- If verification fails twice during a twelve month period, revalidation is required and product should not be labeled until revalidation occurs.
- The dealer in conjunction with the SSCA shall annually evaluate the previous 12 months of data and the HACCP plan.
- The dealer may elect, with SSCA concurrence, to conduct quarterly sampling if the previous 12 verification samples pass.
Verification
Sampling Protocol Decision Tree
Note: When a monthly verification fails, the verification must be reported within one week of failure
References for Vibrio parahaemolyticus
Methods
- Cook, D.W., A. DePaola, and S.A.
McCarthy. 2000. Direct plating procedure for the enumeration of total and
pathogenic Vibrio parahaemolyticus in oyster meats. FDA, Office of
Seafood, Gulf Coast Seafood Laboratory, Dauphin Island, AL. 8 pp.
- Gooch, J.A., A. DePaola, C.A. Kaysner,
and D.L. Marshall. 2001. Evaluation of two direct plating methods using nonradioactive
probes for enumeration of Vibrio parahaemolyticus in oysters. Appl. Environ. Microbiol. 67(2):721-724.
- Kaysner, C.A. and A. DePaola, Jr.
2001. Chapter 40, Vibrio, p. 405-420. In Downes,
F.P. and K. Ito (eds.), APHA Compendium of Methods for the Microbiological
Examination of Foods, 4th Edition, 2001, American Public Health
Association, Washington. D.C.
- McCarthy, S.A., A. DePaola, C.A. Kaysner,
W.E. Hill, and D.W. Cook. 2000. Evaluation of nonisotopic DNA hybridization
methods for detection of the tdh gene of Vibrio parahaemolyticus.
J. Food Protect. 63(12):1660-1664.
- McCarthy, S.A., A. DePaola, D.W. Cook,
C.A. Kaysner, and W.E. Hill. 1999. Evaluation of alkaline phosphatase- and digoxigenin-labeled
probes for detection of the thermolabile hemolysin (tlh) gene of Vibrio
parahaemolyticus. Letters in Applied Microbiology 28(1):66-70.
- McCarthy, S.A., A. DePaola, C.A. Kaysner,
W.E. Hill, and D.W. Cook. 1999. P1. Comparison of PCR and DNA hybridization
methods for detection of the tdh gene of Vibrio parahaemolyticus,
p. 512. In American Society for Microbiology (ed), Abstracts of the
99th General Meeting of the American Society for Microbiology. American
Society for Microbiology, Washington, D.C.
References
- Bachman, B. et al. 1983. Marine Noncholera
Vibrio Infections in Florida. So. Med. Jour. 76:296-303.
- Baross, J. and J. Liston. 1970.
Occurrence of Vibrio parahaemolyticus and Related Hemolytic Vibrios in
Marina Environments of Washington State. Appl. Microbiol. 20:179-186.
- Blake, P.A. et al. 1979. Disease
Caused by a Marine Vibrio, Clinical Characteristics and Epidemiology. N. Eng. J. Med. 300: 1-5.
- Blake, P.A. et al. 1980. Disease of Humans (Other Than Cholera Caused by Vibrios). Ann.
Rev. Microbiol. 34:341-367.
- Blake, P.A. 1983. Vibrios on The Half
Shell: What the Walrus and the Carpenter Didn't Know. Ann. of Int. Med.
99:558-559.
- Blake, P.A. 1984. Prevention of
Food-Borne Disease Caused by Vibrio Species. In: Colwell, R.R., et al., eds. Vibrios
in the Environment. John Wiley and Sons. New
York, NY. pp. 579-590.
- Bonner, J.R. et al.
1983. Spectrum of Vibrio Infections in a Gulf
Coast Community. Ann. Intern. Med. 99:464-469.
- Colwell, R.R. 1984. Vibrios In The
Environment In: Colwell, R.R.; et al., eds. Vibrios in the Environment.
John Wiley & Sons. New York, NY. pp. 1-12.
- Davey, G.R. et al. 1982. Detection of Vibrio cholerae In Oysters, Water And
Sediment From The Georges River. Food Technol. Aust. 34:334-336.
- DePaola, A. 1981. Vibrio cholerae in
Marine Foods and Environmental Waters. A literature review. Jour. of Food Sci.
46:66-70.
- Desmarchelier, P.M. 1984. Significance Of Vibrio spp. in Foods. Food Technol. Aust. 36:220-222.
- Food and Drug Administration. 1985. Vibrio vulnificus and Patients with Liver Disease. In: FDA Drug Bulletin.
April. 15(1):5-6.
- Joseph, S.W. et al. 1982. Vibrio
parahaemolyticus And Related Halophilic Vibrios. CRC Crit. Rev. in Microbiol.
10:77-124.
- Madden, J.M. et al. 1982. Vibrio
cholerae. In Shellfish From U.S. Coastal Waters. Food Tech. 36(3):93-96.
- Morris, J.G. Jr. et al. 1981. Non-O
group 1 Vibrio cholerae Gastroenteritis in the United States. Ann.
of Int. Med. 94:656-658.
- Morris, J.G., Jr. et al.
1985. Cholera And Other Vibrioses In
The United States. N. Engl. J. Med. 312:343-350.
- National Institute of Health (NIH). 1984. Highly Invasive New Bacterium Isolated From U.S. East Coast Waters. JAMA. 251:323-325.
- Oliver, J.D. 1982. The Pathogenicity
and Ecology of Vibrio vulnificus. Marine Tech. Soc. Jour.
15:45-52.
- Oliver, J.D. et al. 1983. Distribution
of Vibrio vulnificus and Other Lactose-Fermenting Vibrios in The Marine
Environment. Appl. Environ. Microbiol. 45:985-998.
- Rodrick, G.E. et al.
1982. Human Vibrio Gastroenteritis, Symposium
On Intestinal Infections. Med. Clinics of North Amer. 66:665-673.
- Spira, W.M. 1984. Tactics For Detecting Pathogenic Vibrios In The
Environment. In: Colwell, R.R. et al., eds. Vibrios in the
Environment. John Wiley & Sons. New
York, NY pp 251-268.
- Tacket, C.O., et al. 1984. Clinical
Features and an Epidemiological Study of Vibrio vulnificus Infections. Jour. Infect. Dis. 149:558-561.
- Tamplin, M., et al. 1982. Isolation and Characterization of Vibrio vulnificus From Two Florida Estuaries. Appl.
Environ. Microbiol. 44:1466-1470.
- Watkins, W. and S. McCarthy. 1994. Proceedings
of the 1994 Vibrio vulnificus Workshop. U.S. Department of Health and Human
Services, Public Health Service, Office of Seafood (HFS-400), Shellfish
Sanitation Branch, 200 C Street, SW, Washington, D.C. 175 pages.
Description: Flow chart showing the post harvest processing verification sampling protocol and decision making process.
Collect monthly shellfish meat samples for process verification.
If the monthly samples pass, no action is required.
If the monthly samples fail, take the following measures; (1) Identify the problem, (2) Fix the problem, (3) re-verify the process by sampling. If the re-verification samples pass, no further action is required. If the re-verification samples fail, then; (1) Corrective action must be taken on the product, (2) The process must be investigated, (3) Any problems identified must be adjusted, and (4) The process shall be revalidated. No labeling claims can be made during the interim revalidation process.
If the monthly samples fail and no problem can be identified then; (1) Adjustments shall be made to the process, and (2) The process shall be revalidated. No labeling claims can be made during the interim revalidation process.